At the same time, the introduction of exosomes themselves into Alzheimer’s disease models led to an improvement in cognitive functions, which was associated with an increase in BDNF levels in the brain and a decrease in oxidative stress [98]. This evidence concerns the gene BDNF and Alzheimer disease.